Medullary thyroid cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-000-0052-7.pdf
Reference43 articles.
1. Hazard JB, Hawk WA, Crile GJ: Medullary (solid) carcinoma of the thyroid—a clinicopathologic entity. J Clin Endocrinol Metab 1959, 19:152–161.
2. Gilliland FD, Hunt WC, Morris DM, Key CR: Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the surveillance, epidemiology and end results (SEER) program 1973–1991. Cancer 1997, 79:564–573.
3. Hundahl SA, Fleming ID, Fremgen AM, Menck HR: A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998, 83:2638–2648.
4. Kebebew E, Ituarte PHJ, Siperstein AE, et al.: Medullary thyroid cancer: clinical characteristics, treatment, prognostic factors and a comparison of staging systems. Cancer 2000, 88:1139–1148. A univariate and multivariate analysis study of prognostic factors for medullary thyroid cancer and treatment outcome of patients with medullary thyroid cancer.
5. Ponder BA, Ponder MA, Coffey R, et al.: Risk estimation and screening in families of patients with medullary thyroid carcinoma. Lancet 1988, 1:397–401.
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study;EJNMMI Research;2023-07-17
2. Tumori del corpo tiroideo: epidemiologia, clinica, valutazione;EMC - Otorinolaringoiatria;2022-08
3. Tumores del cuerpo de la glándula tiroidea: epidemiología, clínica y estudio;EMC - Otorrinolaringología;2022-07
4. Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms;Cancer Imaging;2022-06-03
5. In silico Analysis of Publicly Available Transcriptomics Data Identifies Putative Prognostic and Therapeutic Molecular Targets for Papillary Thyroid Carcinoma;International Journal of General Medicine;2022-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3